Home › Parkinson's Disease › NCT06442033
Genetics and Aerobic Exercise to Slow Parkinson's Disease Trial
Genetics and Aerobic Exercise to Slow Parkinson's Disease (GEARS) Trial
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Adult with a diagnosis of PD by a physician or physician extender 2. Hoehn and Yahr stage I-III 3. Demonstrate the ability to safely mount and dismount a stationary cycle 4. Reliable transportation to the community exercise facility 5. Smartphone device for activity data monitoring 6. On a stable dose of anti-parkinsonian medication Exclusion Criteria: 1. Participation in disease modifying PD-related clinical trial or study 2. Diagnosis of dementia or any neurocognitive impairment that compromises one's ability to provide informed consent. 3. Implanted deep brain stimulation electrodes or focused ultrasound for PD management 4. Recommendation for medical clearance using the American College of Sports Medicine (ACSM) Preparticipation Health Screen a. If the ACSM screen recommends medical clearance, the participant must obtain medical clearance by their health care provider prior to participation. b. Those who choose not to obtain physician clearance will not be eligible for participation. e) A musculoskeletal issue (arthritis, osteoporosis, back problem) that would limit one's ability to engage in a cycling intervention f) Neurological disease other than Parkinson's disease (i.e. multiple sclerosis, stroke) g) Current cardiac arrhythmia
About the study
The proposed multi-site, Genetics and Aerobic Exercise to Slow PD (GEARS) Trial will, for the first time, determine the interplay between genetics and exercise in altering PD progression. In sum, 200 PD patients will be recruited from the Cleveland and Salt Lake City metro areas to participate in the Pedaling for Parkinson's (PFP) community-based exercise program. Participants will exercise at community-based sites 3x/week for 12 months. All participants will undergo genotyping using an array that includes the genome backbone and common risk variants associated to increase risk for multiple neurological disorders including PD.
What is being tested
- High intensity stationary cycling (other)
Sponsor: Jay Alberts · Participants: 200 · Started: Aug 23, 2024
Contact the study team
- Elizabeth Jansen, MPH · Phone: 216-780-9160
- Anson Rosenfeldt, DPT · Phone: 216-644-7617
Official record on ClinicalTrials.gov — NCT06442033
Locations in the U.S.
| Ohio | The Cleveland Clinic, Cleveland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.